Next Quarterly Earnings
Date confirmed from the company's own financial calendar.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Xvivo Perfusion is a leading Swedish medical technology company specializing in innovative organ perfusion and preservation solutions. The company aims to optimize donor organs for successful transplantation, thereby improving patient outcomes globally.
Date confirmed from the company's own financial calendar.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Xvivo Perfusion is scheduled to report its next quarterly earnings on 10/22/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
Xvivo Perfusion last reported quarterly earnings on 7/14/2026 (Q2 2026). Earnings per share (EPS) came in at 0.65 SEK.
Across its last 4 earnings reports, Xvivo Perfusion stock moved by ±4% on average the following day. The largest reaction was -5.9% on 04/24/2026; 3 of 4 reactions were positive.
Xvivo Perfusion has beaten analyst EPS estimates in 2 of its last 4 evaluated quarters (beat rate: 50%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 4 report dates (close to close).
Basis: 4 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.